Prospective Study Deltamotion - DAA THA Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01474031|
Recruitment Status : Terminated (Main investigator has left the department and therefore the study had ended)
First Posted : November 17, 2011
Last Update Posted : November 18, 2020
Introduction Few gait analytical data are available concerning the Direct Anterior Approach (DAA) in total hip arthroplasty (THA). All the studies have focused on immediate post-operative recovery. These studies have in general some important shortcomings in order to accurately evaluate the biomechanics of the replaced hip joint. None of the published reports have reported on consecutive intervals of pre-op - 6w - 3m - 6m - 12m. This is of interest as we know that recovery with other approaches takes >1 year. It might be that the DAA approach leads to normal gait patterns at 3m or 6m and that these patterns do not differ from the normal pattern or at >1y post-op. None of the reports utilized out-of-plane movements such as coming down or up stairs or squads. Utilizing trunk markers is frequently not done but it is important to evaluate the centre of mass position during gait. Very few studies utilize kinetic data, which are important in order to thoroughly evaluate the biomechanics and loading of the hip. And maybe most importantly, the biomechanical effect of the diameter of the articulating surface on gait parameters following the DAA has never been evaluated.
One of the most important advantages of the DAA is the muscle sparing aspect and the presumption that the femoral anatomy and biomechanics can be more accurately and precisely restored. If the diameter of the articulating surface has then also been reconstructed to the almost anatomical diameter, we can assume that this should be the most optimal reconstruction of the hip joint currently available. This could lead to early return to normal gait, to optimal joint loading and a minimal amount of stress shielding of the femoral bone.
The aim of this project is to prospectively analyse the biomechanics of the hip joint of a THA with a Deltamotion articulating surface utilizing the Direct Anterior Approach.
- Materials and Methods Hypothesis: The temporo-spatial parameters (velocity, cadence, step length, and stride length) and gait kinematic and kinetic data (external hip and knee muscle moments) are not significantly different between the study and control group at the evaluated time intervals indicating normal or near normal gait patterns in the early post-operative recovery phase.
|Condition or disease||Intervention/treatment|
Estimated inclusion time: 1 July 2011 - 31 December 2013 Cohorts: 20 DAA subjects - 20 control subjects
- Time interval: pre-op - 3m - 6m - 12m
Gait analysis with surface EMG and trunk markers:
- Unipodal standing: 3 trials Right and 3 trials Left on FP
- Level walking: 3 trials Right and 3 trials Left on FP
- Chair rise: 3 trials, both legs on FP
- Stair ascent: 3 trials Right and 3 trials Left on first FP
- Stair descent: 3 trials Right and 3 trials Left on first FP
- Squat: 3 trials, both legs on FP
- Bipodal squat: 3 trials Right and 3 trials Left on FP
- Functional scores (HHS, UCLA, HOOS, SF-36)
|Study Type :||Observational|
|Actual Enrollment :||29 participants|
|Official Title:||Prospective Study Deltamotion - DAA THA Study|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||July 2013|
|Actual Study Completion Date :||July 2013|
20 DAA subjects
20 DAA subjects: THA with a Deltamotion articulating surface utilizing the Direct Anterior Approach
- biomechanics [ Time Frame: 0.5 year ]prospectively analyse the biomechanics of the hip joint of a THA with a Deltamotion articulating surface utilizing the Direct Anterior Approach
- bone remodelling [ Time Frame: 1 year ]assess the femoral bone remodelling around the fully coated Corail stem over the first year post-operatively.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01474031
|Leuven, Belgium, 3000|
|Principal Investigator:||Kristoff Corten, Doctor||UZ Pellenberg|